Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal remimazolam for preoperative pediatric sedation
ChiCTR2200059493Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in preoperative anxiety, sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Ramsay sedation score. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2200059493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059493.